These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 24678935)

  • 61. Circulating miRNAs as biomarkers for endocrine disorders.
    Butz H; Kinga N; Racz K; Patocs A
    J Endocrinol Invest; 2016 Jan; 39(1):1-10. PubMed ID: 26015318
    [TBL] [Abstract][Full Text] [Related]  

  • 62. MicroRNAs as potential circulating biomarkers for amyotrophic lateral sclerosis.
    Cloutier F; Marrero A; O'Connell C; Morin P
    J Mol Neurosci; 2015 May; 56(1):102-12. PubMed ID: 25433762
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Increased number of circulating exosomes and their microRNA cargos are potential novel biomarkers in alcoholic hepatitis.
    Momen-Heravi F; Saha B; Kodys K; Catalano D; Satishchandran A; Szabo G
    J Transl Med; 2015 Aug; 13():261. PubMed ID: 26264599
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Circulating microRNAs as biomarkers for disease staging in multiple sclerosis.
    Gandhi R; Healy B; Gholipour T; Egorova S; Musallam A; Hussain MS; Nejad P; Patel B; Hei H; Khoury S; Quintana F; Kivisakk P; Chitnis T; Weiner HL
    Ann Neurol; 2013 Jun; 73(6):729-40. PubMed ID: 23494648
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Circulating microRNAs as biomarkers in progressive multiple sclerosis.
    Vistbakka J; Elovaara I; Lehtimäki T; Hagman S
    Mult Scler; 2017 Mar; 23(3):403-412. PubMed ID: 27246141
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Role of MicroRNA Let-7 in Modulating Multifactorial Aspect of Neurodegenerative Diseases: an Overview.
    Shamsuzzama ; Kumar L; Haque R; Nazir A
    Mol Neurobiol; 2016 Jul; 53(5):2787-2793. PubMed ID: 25823513
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical proteomics in neurodegenerative disorders.
    Zetterberg H; Rüetschi U; Portelius E; Brinkmalm G; Andreasson U; Blennow K; Brinkmalm A
    Acta Neurol Scand; 2008 Jul; 118(1):1-11. PubMed ID: 18279484
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Absolute Measurement of Cardiac Injury-Induced microRNAs in Biofluids across Multiple Test Sites.
    Thompson KL; Boitier E; Chen T; Couttet P; Ellinger-Ziegelbauer H; Goetschy M; Guillemain G; Kanki M; Kelsall J; Mariet C; de La Moureyre-Spire C; Mouritzen P; Nassirpour R; O'Lone R; Pine PS; Rosenzweig BA; Sharapova T; Smith A; Uchiyama H; Yan J; Yuen PS; Wolfinger R
    Toxicol Sci; 2016 Nov; 154(1):115-125. PubMed ID: 27605421
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Searching for MIND: microRNAs in neurodegenerative diseases.
    Barbato C; Ruberti F; Cogoni C
    J Biomed Biotechnol; 2009; 2009():871313. PubMed ID: 19707536
    [TBL] [Abstract][Full Text] [Related]  

  • 70. MicroRNAs in glaucoma and neurodegenerative diseases.
    Molasy M; Walczak A; Szaflik J; Szaflik JP; Majsterek I
    J Hum Genet; 2017 Jan; 62(1):105-112. PubMed ID: 27412874
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Gene networks in neurodegenerative disorders.
    Recabarren D; Alarcón M
    Life Sci; 2017 Aug; 183():83-97. PubMed ID: 28623007
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Proteomics of human cerebrospinal fluid: discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics.
    Kroksveen AC; Opsahl JA; Aye TT; Ulvik RJ; Berven FS
    J Proteomics; 2011 Apr; 74(4):371-88. PubMed ID: 21111852
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Dysregulated Serum MicroRNA Expression Profile and Potential Biomarkers in Hepatitis C Virus-infected Patients.
    Zhang S; Ouyang X; Jiang X; Gu D; Lin Y; Kong SK; Xie W
    Int J Med Sci; 2015; 12(7):590-8. PubMed ID: 26283876
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Identification of a panel of five serum miRNAs as a biomarker for Parkinson's disease.
    Ding H; Huang Z; Chen M; Wang C; Chen X; Chen J; Zhang J
    Parkinsonism Relat Disord; 2016 Jan; 22():68-73. PubMed ID: 26631952
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The miRNA Mirage: How Close Are We to Finding a Non-Invasive Diagnostic Biomarker in Endometriosis? A Systematic Review.
    Agrawal S; Tapmeier T; Rahmioglu N; Kirtley S; Zondervan K; Becker C
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29463003
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Deciphering the function and regulation of microRNAs in Alzheimer's disease and Parkinson's disease.
    Qiu L; Zhang W; Tan EK; Zeng L
    ACS Chem Neurosci; 2014 Oct; 5(10):884-94. PubMed ID: 25210999
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Can malondialdehyde be used as a biological marker of progression in neurodegenerative disease?
    Dib M; Garrel C; Favier A; Robin V; Desnuelle C
    J Neurol; 2002 Apr; 249(4):367-74. PubMed ID: 11967639
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Transcranial Magnetic Stimulation for the Assessment of Neurodegenerative Disease.
    Vucic S; Kiernan MC
    Neurotherapeutics; 2017 Jan; 14(1):91-106. PubMed ID: 27830492
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Utility of autoantibodies as biomarkers for diagnosis and staging of neurodegenerative diseases.
    DeMarshall C; Sarkar A; Nagele EP; Goldwaser E; Godsey G; Acharya NK; Nagele RG
    Int Rev Neurobiol; 2015; 122():1-51. PubMed ID: 26358889
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clinical Application of Circulating MicroRNAs in Parkinson's Disease: The Challenges and Opportunities as Diagnostic Biomarker.
    Ramaswamy P; Yadav R; Pal PK; Christopher R
    Ann Indian Acad Neurol; 2020; 23(1):84-97. PubMed ID: 32055127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.